Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
Clinical trial NCT03822078 · COMPLETED
Trial details
- NCT number
- NCT03822078
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-30
- Primary completion
- 2004-12-24
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.